Achillion Pharmaceuticals, Inc. (NASDAQ: ACHN) today announced that it has received a Phase 1 Small Business Innovation Research Grant (SBIR) ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE